UNDERSTANDING THE NASH EPIDEMIC: FROM RISK FACTORS TO TREATMENT ADVANCES

Nonalcoholic steatohepatitis (NASH) is a progressive liver condition resulting from fat buildup, leading to inflammation and fibrosis. If not managed properly, it can advance to cirrhosis and liver failure. As an advanced form of nonalcoholic fatty liver disease (NAFLD), NASH is strongly associated with obesity and metabolic disorders. The growing